Executive Searches
President & Chief Executive Officer
Pharmaceuticals
We are no longer accepting applications for this role.
Position Summary
The President & Chief Executive Officer will report to the Board of Directors and take full strategic and operational responsibility for a publicly traded corporation that, while profitable with competitive products, sits at an inflection point requiring significant strategic and operational change. The CEO will develop and execute a plan to move the company to its next level of fiscal and marketplace health, overseeing a full executive team including the CFO, EVP Commercial, EVP Operations, General Counsel, and functional heads of HR, IT, R&D and Quality.
Immediate priorities include rapidly assessing the organization’s current state, evaluating the executive team and structure, and building a strategic plan to restore target EBITDA levels, alongside putting in place repeatable systems and processes that become part of the company’s culture.
Successful Placement
Our placement is a seasoned pharmaceutical executive with a proven track record of P&L and general management leadership across public specialty and generics businesses. Most recently, they led a $600 million generics division as part of a publicly traded specialty pharmaceutical company, and previously served as CEO of a major generics business, growing revenue at a 20%+ CAGR while restoring product supply and customer reputation. Earlier in their career, they held senior general management and strategy roles across several large pharmaceutical and consumer organizations, consistently driving growth through acquisitions, new product launches and operational turnarounds.
As announced by the company, “Douglas S. Boothe has been named president and chief executive officer effective January 1, 2019, bringing deep pharmaceutical expertise and a proven track record as Akorn looks forward to its next phase as an independent company committed to rebuilding shareholder value.
Boothe is an industry veteran with extensive accomplishments in the specialty, generic and over-the-counter pharmaceuticals business. He brings to Akorn a long history of senior-level expertise in general management, strategy, sales and marketing, product selection, supply chain and business development in the US and global arenas.”
